Aurora Caddell, director of pharmacy at St. Lawrence Hospital (SLH), oversees pharmacy services and medication costs at the hospital. In April 2024, the senior leadership team mandated all programs to identify a minimum of 3 per cent cost savings without impacting service levels or access to patient care. After discussion with her management team, it seems to Caddell that the only viable opportunity to reduce costs without impacting service levels is to start producing six high-volume intravenous (IV) medications in-house that SLH currently outsources to a for-profit company, Lincoln Comprehensive Compounders. In order to do so, SLH pharmacy could either increase staff numbers or purchase an IV compounding robot. However, Caddell is uncertain which course of action is best.
看看哪些人也有訂購？